期刊文献+

干扰素体外释放酶联免疫法在结核潜伏感染诊断中的价值 被引量:8

Evaluation of the value of Quantitative Diagnostic Kit for Mycobacterium tuberculosis-IFN-γ release assay in screaming latent Mtb infection diagnosis
暂未订购
导出
摘要 目的探讨干扰素体外释放酶联免疫法(TB-IGRA)在诊断诊断结核分枝杆菌潜伏感染的价值。方法分枝杆菌相关γ-干扰素检测试剂盒(WT-IGRA)检测140例健康者IFN-γ分泌水平,并对其进行结核菌素皮试及采用Cellestis Limited生产的QuantiFERON-TB试剂盒进行IFN-γ平行检测。结果 140例健康者中,WT试剂和QFT试剂阳性率分别是25.7%(36/140)、21.4%(30/140),PPD3+~4+为14.3%(20/140)。两试剂阳性符合率为81.3%,阴性符合率为88.9%,总符合率86.7%。28例密接者中,PPD3+~4+为39.3%(11/28),WT试剂和QFT试剂阳性率分别是46.4%(13/28)和67.8%(19/28)。结论 TB-IGRA在诊断结核分枝杆菌潜伏感染的价值优于PPD皮试,可以用于潜伏感染者的筛查。 Objective To investigate the clinical value of the Quantitative Diagnostic Kit for Mycobacterium tuberculosis-IFN-γrelease assay(TB-IGRA) in diagnosing latent Mycobaterium tuberculosis infection.Methods 140 subjects were analyzed;antigen specific-IFN response were determined by using regents from two suppliers,Quantitative Diagnostic Kit for Mycobacterium tuberculosis-IFN-γ release assay(WT-IGRA) and QuantiFERON-TB GOLD in tube(QFT-GIT,Cellestis Limited,Australia).Subjects received PPD skin test as well.Results Among 140 subjects,the positive rates of TB-IGRA with WT and QFT-G were 25.7(36/140),21.4%(30/140),PPD3+~4+ was 14.3%(20/140).The positive consistency of two kits was 81.3%,negative consistency was 88.9%,total consistency was 86.7%.Among 28 close contacts,their PPD3+~4+was 39.3%(11/28),WT and QFT positive rates were 46.4%(13/28) and 67.8%(19/28).Conclusions The diagnostic value of latent Mtb infection of TB-IGRA is higher than that of PPD method,TB-IGRA can be used as a screening method for latent Mtb infection patients.
出处 《临床肺科杂志》 2012年第6期1062-1064,共3页 Journal of Clinical Pulmonary Medicine
关键词 结核分枝杆菌潜伏感染 干扰素释放试验 结核菌素皮试 latent Mtb infection IFN-γ release assay PPD skin test
  • 相关文献

参考文献7

  • 1Peter A, Aark Doherty, Madhukar P. The prognosis of latent tuber- culosis:can disease be predicted [ J] .9 Trends in Medicine, 2007,13 (6) :175 -182.
  • 2Germ H. Mazurek, Margarita E. Villarino. Guidelines for using the Quanti FERON-TB-Gold test for detecting Mycobacterium tuberculo- sis infection[ J]. MMWR,2005,54(6) :49 - 55.
  • 3Alfred A Lardizabal, Lee B Reichman. Interferon-gamma release as- say for detection of tuberculosis infection [ J ]. US Respiratory dis- ease ,2006,54:59 - 61.
  • 4肖松生,杨倩婷,蔡雄茂,张明霞,朱秀云,吴庆军,陈心春.外周血IFN-γ的检测在结核分枝杆菌潜伏感染诊断中的价值[J].临床肺科杂志,2008,13(10):1251-1253. 被引量:20
  • 5Sester M, Sotgiu G, Lange C, et al. Interferon-y release assays forthe diagnosis of latent Mycobacterium tuberculosis infection : a sys- tematic review and meta-analysis[ J ]. Eur Respir J, 2011,37 ( 1 ) : 88 - 99.
  • 6Mahairas GG, Sabo PJ, Hickey M J, et al. Molecular analysis of genet- ic differences between mycobacterium boris BCG and virulent M. bovis [ J ]. Bacteriol, 1996,178 (5) : 1274 - 1282.
  • 7Brodie D, Lederer DJ, Gallardo JS, et al. Use of an interferon-gam- ma release assay to diagnose latent tuberculosis infection in foreign- born patients[J]. Chest, 2008, 133(4) :869 -874.

二级参考文献8

  • 1Peter Anderden, T. Aark Doherty, Madhukar Pal and Karin Welding. The prognosis of latent tuberculosis : can disease be predicted? Trends in Medicine,2007,13 (6), 175 - 182.
  • 2Geral H. Mazurek, M D, Margarita E. Villarino, M D, et al. Guidelines for using the Quanti FERON-TB-Glod test for detecting Mycobacterium tuberculosis infection. MMWR,2005,54 (6) ,49 - 55.
  • 3Alfred A Lardizabal, M D, Lee B Reichman, M D, MPH. Interferon- Gamma release assay for detection of tuberculosis infection. US Respiratory Disease,2006,54 (6) ,59 - 61.
  • 4Arend SM, Geluk A, Van Meijgaarden KE, et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kd protein and culture filtrate protein 10. J Infect Dis ,2000,181 ( 10), 1850 - 1854.
  • 5Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med,2001,163 (21), 824- 828.
  • 6Ajit Lalvani, Ansar A Pathan, Helen Durkan, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-spceific T cells. The Lancet, 2001,357 ( 56 ) : 2017 - 2021.
  • 7P Andersen, M E Munk, F M Pollock, T M Doherty. Specific immunebased diagnosis of tuberculosis. The Lancet,2000,356 (9235) :1099- 1104.
  • 8Luca Richeldi. An Update on the Diagnosis of Tuberculosis Infection. Amercan Journal of Respiratory and Critical Care Medicine,2006,174 (7) :736 -742.

共引文献19

同被引文献50

  • 1夏晓黎,毛菊秀,叶军.支气管肺泡灌洗在肺结核病原学诊断上的临床应用[J].临床肺科杂志,2005,10(6):805-805. 被引量:6
  • 2Young DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis [J]. Trends Microbiol, 2009, 17(5), 183-188.
  • 3Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. The spectrum of latent tuberculosis, rethinking the biology and intervention strategies [J]. Nat Rev Microbiol, 2009, 7 (12), 845-855.
  • 4Mazurek GH, Jereb J, Lobue p, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States [J]. MMWR Recomm Rep, 2005, 54 (RR-15), 49-55.
  • 5Dogra S, Narang P, Mendiratta DK, Chaturvedi r. Reingold AL, Colford JM Jr, Riley LW, Pai M. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India [J]. J Infect, 2007, 54(3), 267-276.
  • 6Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT. TB in children [J]. PLoS One, 2008,3(7), e2624.
  • 7Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K. Interferon-gamma release assays improve the diagnosis of tuberculosis and non tuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis [J]. Clin Infect Dis, 2007, 45(3), 322-328.
  • 8Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya EN, Kowour D, Rojas-Ponce G, Kroidl A, Maboko L, Heinrich N, Reither K, Hoelscher M. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis, a prospective cohort study [J]. Clin Infect Dis, 2012, 54(10), 1388-1396.
  • 9Snider DE JI. Bacille Calmette-Guerin vaccinations and tuberculin skin tests [J]. JAMA, 1985, 253 (23), 3438-3439.
  • 10Judson FN, Feldman RA. Mycobacterial skin tests in humans 12 years after infection with Mycobacterium marinum [J]. Am Rev Respir Dis, 1974, 109(5), 544-547.

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部